Literature DB >> 28116745

Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report.

Elif Atag1, Huseyin Salih Semiz2, Seher Nazli Kazaz2, Emine Burcin Tuna3, Ozhan Ozdogan4, Ozan Bozkurt5, Omer Demir5, Aziz Karaoglu2.   

Abstract

Penile metastases are extremely rare events and generally occurs at a late stage of primary disease. They mostlyoriginate from prostate and bladder in the genitourinary tract. Penile metastases have a dismal prognosis and verylow survival rates. We report a case of penile metastasis in 70-year-old geriatric male patient with prostatic adenocarcinomawho was treated with cabazitaxel chemotherapy beyond 20 cycles with a good response and acceptableminimal toxicity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28116745

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  5 in total

Review 1.  The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer.

Authors:  Martina Pagliuca; Carlo Buonerba; Karim Fizazi; Giuseppe Di Lorenzo
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

2.  Case Report: 18F-PSMA PET/CT May Improve the Clinical Management of Penile Metastases From Prostate Cancer.

Authors:  Junjie Fan; Hua Liang; Xing Zhang; Xingfa Chen; Xiaoyi Duan; Lei Li; Dalin He; Kaijie Wu
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

3.  Malignant priapism in metastatic prostate cancer: A late event occurring early.

Authors:  Odeth Barrett-Campbell; Iva Petkovska; Susan F Slovin
Journal:  Urol Case Rep       Date:  2018-03-31

4.  Cystic metastasis of prostate cancer: A case report.

Authors:  Bei Zhang; Bingyang Bian; Lirong Bi; Zhuo Wang; Yang Zhao; Jiping Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.

Authors:  Shigehisa Kubota; Susumu Kageyama; Masayuki Nagasawa; Akinori Wada; Ryo Ikari; Keiji Tomita; Tetsuya Yoshida; Mitsuhiro Narita; Akihiro Kawauchi
Journal:  Am J Case Rep       Date:  2021-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.